SCHEMBL8949885

SCHEMBL8949885

CNc1ccccc1.CP(=O)(O)P(=O)(O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.61
CA9 Q16790 2/20 0.45
CA12 O43570 1/20 0.45
HSD17B10 Q99714 2/20 0.40
NAPRT Q6XQN6 1/20 0.40
CA2 P00918 2/20 0.39
CA4 P22748 1/20 0.39
CA5A P35218 1/20 0.39
NPSR1 Q6W5P4 1/20 0.38
TP53 P04637 2/20 0.38
EPHX1 P07099 1/20 0.38
EPHX2 P34913 1/20 0.38
CDK9 P50750 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
GFER P55789 1/20 0.38
HPGD P15428 3/20 0.38
CYP3A4 P08684 2/20 0.38
ALDH1A1 P00352 2/20 0.38
ALOX5 P09917 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Methyl Phosphonate SCHEMBL9136984 0.91 TSHR (0.67) TSHRCA9CA12HSD17B10NAPRT
Methyl Phosphonate SCHEMBL9137329 0.89 TSHR (0.64) TSHRCA9CA12HSD17B10NAPRT
SCHEMBL8949926 0.79 FDPS (0.44) TP53EPHX1HPGDALDH1A1FDPS
SCHEMBL8949636 0.79 TSHR (0.50) TSHRCA9CA12HSD17B10NAPRT
Methyl Alcohol SCHEMBL11681702 0.78 TSHR (0.88) TSHRHSD17B10NAPRTTP53EPHX1
Benzene SCHEMBL17977991 0.78 TSHR (1.00) TSHRHSD17B10NAPRTNPSR1TP53
SCHEMBL19298582 0.78 TSHR (1.00) TSHRHSD17B10NAPRTNPSR1TP53
SCHEMBL3008675 0.78
SCHEMBL4454 0.78
SCHEMBL8949897 0.77 TSHR (0.48) TSHRCA9CA12HSD17B10NAPRT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5574024-A Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism EBETINO FRANK H (US) 1996-11-12 US disclosed
EP-0298553-B1 METHYLENE PHOSPHONOALKYLPHOSPHINATES, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM Norwich Eaton Pharmaceuticals, Inc. (US) 1992-01-15 EP disclosed
EP-0298553-A1 Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism Norwich Eaton Pharmaceuticals, Inc. (US) 1989-01-11 EP disclosed